Chemed Corporation $CHE Stock Holdings Decreased by Harbor Capital Advisors Inc.

Harbor Capital Advisors Inc. decreased its stake in shares of Chemed Corporation (NYSE:CHE) by 65.3% during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The fund owned 1,166 shares of the company’s stock after selling 2,197 shares during the period. Harbor Capital Advisors Inc.’s holdings in Chemed were worth $522,000 as of its most recent filing with the SEC.

A number of other hedge funds have also bought and sold shares of the company. Farther Finance Advisors LLC raised its stake in Chemed by 29.6% during the third quarter. Farther Finance Advisors LLC now owns 482 shares of the company’s stock valued at $216,000 after buying an additional 110 shares in the last quarter. Exchange Traded Concepts LLC increased its holdings in shares of Chemed by 27.8% in the 3rd quarter. Exchange Traded Concepts LLC now owns 2,001 shares of the company’s stock valued at $896,000 after acquiring an additional 435 shares during the last quarter. Legacy Wealth Asset Management LLC increased its holdings in shares of Chemed by 4.8% in the 3rd quarter. Legacy Wealth Asset Management LLC now owns 2,548 shares of the company’s stock valued at $1,141,000 after acquiring an additional 117 shares during the last quarter. Diversified Enterprises LLC raised its position in shares of Chemed by 23.6% during the 3rd quarter. Diversified Enterprises LLC now owns 592 shares of the company’s stock valued at $265,000 after acquiring an additional 113 shares in the last quarter. Finally, Signal Advisors Wealth LLC lifted its stake in Chemed by 82.2% during the third quarter. Signal Advisors Wealth LLC now owns 17,466 shares of the company’s stock worth $7,820,000 after purchasing an additional 7,880 shares during the last quarter. 95.85% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity at Chemed

In related news, CEO Kevin J. Mcnamara sold 2,000 shares of Chemed stock in a transaction dated Monday, November 24th. The shares were sold at an average price of $437.55, for a total transaction of $875,100.00. Following the sale, the chief executive officer directly owned 94,197 shares in the company, valued at $41,215,897.35. The trade was a 2.08% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Company insiders own 3.29% of the company’s stock.

Wall Street Analyst Weigh In

Several analysts have weighed in on the stock. Bank of America lowered their target price on shares of Chemed from $610.00 to $595.00 and set a “buy” rating for the company in a research note on Wednesday, September 10th. Zacks Research raised shares of Chemed from a “strong sell” rating to a “hold” rating in a report on Thursday, October 30th. Jefferies Financial Group upgraded shares of Chemed from a “hold” rating to a “buy” rating and increased their price objective for the stock from $490.00 to $550.00 in a research note on Tuesday, September 2nd. Royal Bank Of Canada cut their target price on shares of Chemed from $589.00 to $572.00 and set an “outperform” rating on the stock in a report on Monday, November 10th. Finally, Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Chemed in a report on Wednesday, October 8th. Four investment analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $574.25.

Chemed Stock Down 0.6%

Chemed stock opened at $432.58 on Monday. Chemed Corporation has a 52-week low of $408.42 and a 52-week high of $623.60. The firm has a market capitalization of $6.13 billion, a price-to-earnings ratio of 22.88, a PEG ratio of 2.41 and a beta of 0.46. The firm has a 50-day moving average price of $435.54 and a two-hundred day moving average price of $454.06.

Chemed (NYSE:CHE) last released its quarterly earnings results on Tuesday, October 28th. The company reported $5.27 earnings per share for the quarter, missing analysts’ consensus estimates of $5.39 by ($0.12). Chemed had a net margin of 11.02% and a return on equity of 25.89%. The business had revenue of $624.90 million for the quarter, compared to the consensus estimate of $626.04 million. During the same period last year, the firm posted $5.64 EPS. The business’s quarterly revenue was up 3.1% on a year-over-year basis. Chemed has set its FY 2025 guidance at 22.000-22.300 EPS. Research analysts expect that Chemed Corporation will post 21.43 earnings per share for the current year.

Chemed Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, December 5th. Stockholders of record on Monday, November 17th were paid a $0.60 dividend. The ex-dividend date of this dividend was Monday, November 17th. This represents a $2.40 annualized dividend and a dividend yield of 0.6%. Chemed’s dividend payout ratio is presently 12.69%.

About Chemed

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.